SCHEMBL6763167

SCHEMBL6763167

CC(CNS(=O)(=O)C(C)C)c1ccc2cc(OCCNC(=O)N(C)c3ccccc3)ccc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIA4 P48058 6/20 0.44
GRIA2 P42262 2/20 0.43
CA4 P22748 6/20 0.42
CA12 O43570 4/20 0.42
CA9 Q16790 4/20 0.42
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
MTNR1A P48039 2/20 0.40
MTNR1B P49286 2/20 0.40
HRAS P01112 1/20 0.38
KRAS P01116 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPK1 P28482 1/20 0.38
NTSR1 P30989 1/20 0.38
HTT P42858 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
NOD2 Q9HC29 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6763170 0.88 GRIA4 (0.41) GRIA4CA4CA12CA9CA1
SCHEMBL6762168 0.85 GRIA4 (0.56) GRIA4GRIA2CA4CA12CA9
SCHEMBL6763714 0.83 MTNR1A (0.49) GRIA4CA4CA12CA9CA1
SCHEMBL6759349 0.81 GRIA4 (0.49) GRIA4GRIA2CA4CA12CA9
SCHEMBL6761041 0.81 PPARG (0.58) GRIA4GRIA2KMT2A
SCHEMBL6765777 0.80 ALDH1A1 (0.55) GRIA4GRIA2CA12CA9CA1
SCHEMBL6763752 0.80 CA4 (0.45) GRIA4GRIA2CA4CA12CA9
SCHEMBL6762959 0.78 KDM4E (0.47) GRIA4GRIA2KDM4EALDH1A1
SCHEMBL6763016 0.78 GRIA4 (0.48) GRIA4GRIA2CA4CA12CA9
SCHEMBL6763801 0.78 GRIA4 (0.54) GRIA4GRIA2HRASKRASALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040147612-A1 Sulfonamide derivatives DAVISON JOSHUA ZWICK (US) 2004-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040147612-A1 Sulfonamide derivatives GRIN1, GRIN2A, GRIA1 GRIA4 9/4885GRIA2 7/4885CA4 2818/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.